Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
华尔街最准确的分析师聚焦于3只医疗保健股票，提供高股息收益。
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
在市场动荡和不确定时期，许多投资者转向股息收益率股票。这些公司通常具有较高的自由现金流，并以高额的股息支付来奖励股东。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga的读者可以通过访问分析师股票评级页面来查看分析师对他们最喜欢的股票的最新看法。交易者可以对Benzinga庞大的分析师评级数据库进行排序，包括按分析师的准确性进行排序。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是最准确的分析师对医疗保健行业三只高收益股票的评级。
Amgen Inc. (NASDAQ:AMGN)
安进公司（纳斯达克股票代码：AMGN）
- Dividend Yield: 3.67%
- Piper Sandler analyst David Amsellem maintained an Overweight rating and cut the price target from $344 to $310 on Jan. 2. This analyst has an accuracy rate of 66%.
- B of A Securities analyst Tim Anderson reinstated an Underperform rating with a price target of $256 on Dec. 10. This analyst has an accuracy rate of 63%.
- Recent News: On Dec. 10, Amgen increased its first-quarter dividend by 6% from $2.25 to $2.38 per share.
- Benzinga Pro's real-time newsfeed alerted to latest AMGN news.
- 股息收益率：3.67%
- 派珀·桑德勒分析师戴维·阿姆塞勒姆维持增持评级，并于1月2日将目标股价从344美元下调至310美元。这位分析师的准确率为66％。
- b of A 证券分析师蒂姆·安德森于12月10日恢复了表现不佳的评级，目标股价为256美元。这位分析师的准确率为63％。
- 最新消息：12月10日，安进将其第一季度股息从每股2.25美元提高了6％，至2.38美元。
- Benzinga Pro的实时新闻提醒了AMGN的最新消息。
AbbVie Inc. (NYSE:ABBV)
艾伯维公司（纽约证券交易所代码：ABBV）
- Dividend Yield: 3.66%
- B of A Securities analyst Tim Anderson reinstated a Neutral rating with a price target of $191 on Dec. 10. This analyst has an accuracy rate of 63%.
- Leerink Partners analyst David Risinger upgraded the stock from Market Perform to Outperform with a price target of $206 on Nov. 22. This analyst has an accuracy rate of 75%.
- Recent News: On Dec. 13, AbbVie announced plans to acquire Nimble Therapeutics.
- Benzinga Pro's real-time newsfeed alerted to latest ABBV news
- 股息收益率：3.66%
- b of A 证券分析师蒂姆·安德森于12月10日恢复了中性评级，目标股价为191美元。这位分析师的准确率为63％。
- Leerink Partners分析师戴维·里辛格于11月22日将该股从市场表现上调至跑赢大盘，目标股价为206美元。该分析师的准确率为75％。
- 最新消息：12月13日，艾伯维宣布了收购Nimble Therapeutics的计划。
- Benzinga Pro 的实时新闻提醒注意最新的 ABBV 新闻
CVS Health Corporation (NYSE:CVS)
CVS 健康公司（纽约证券交易所代码：CVS）
- Dividend Yield: 6.02%
- Deutsche Bank analyst George Hill upgraded the stock from Hold to Buy with a price target of $66 on Dec. 3. This analyst has an accuracy rate of 60%.
- Truist Securities analyst David Macdonald reiterated a Buy rating and lowered the price target from $76 to $67 on Nov. 20. This analyst has an accuracy rate of 63%.
- Recent News: The DOJ recently alleged that CVS violated the Controlled Substances Act by filling unlawful prescriptions for opioid combinations and excessive quantities since 2013.
- Benzinga Pro's charting tool helped identify the trend in CVS stock.
- 股息收益率：6.02%
- 德意志银行分析师乔治·希尔于12月3日将该股从持有上调至买入，目标股价为66美元。这位分析师的准确率为60％。
- Truist Securities分析师戴维·麦克唐纳重申了买入评级，并于11月20日将目标股价从76美元下调至67美元。这位分析师的准确率为63％。
- 最新消息：美国司法部最近指控自2013年以来，CVS开具了非法的阿片类药物组合处方和过量处方，从而违反了《管制物质法》。
- Benzinga Pro的图表工具帮助确定了CVS股票的走势。
Read More:
阅读更多：
- How To Earn $500 A Month From Acuity Brands Stock Ahead Of Q1 Earnings
- 如何在第一季度财报之前从Acuity Brands的股票中每月赚取500美元
资讯热榜
更新时间